Oxford Science Enterprises reposted this
Welcome to Dr Mark Bodmer as CEO of Nucleome Therapeutics. https://lnkd.in/ebXAVgJF. Commenting, Mark said: “Nucleome has built a revolutionary technology platform which moves the field of genetics in medicine from its 1-Dimensional linear code to the interactions within its 3-Dimensional structure. This allows us to determine the regulatory wiring of gene function in health and disease in unprecedented detail. Variants in non-coding regions of the genome can be mapped to the genes they control, which are often far away in 1-D but are next-door neighbours in 3-D. Nucleome’s uniquely powerful technology fills a critical gap in the application of genetics to drug discovery and healthcare. The vast majority of genome sequence variants lie outside of protein-coding regions. Yet they play a critical role in shaping biological function and disease. Nucleome’s capability to bridge these sequence variants to biology brings genomics into an entirely new era of the application of genetics to drug target discovery and precision medicine. It is a privilege to be given the opportunity to lead this ground-breaking company into its next phase of growth.” #CEO #hiring #biotech #genomics
Congratulations. Looking forward to seeing what this leads to.
Congratulations Mark - I will be looking for all the great news to follow! Please give my regards to the Lion King!
Congratulations Mark 👏👏👏
A hearty congratulations Mark! Wishing you and Nucelome the best!
Congratulations!
Congratulations!
Congratulations Mark!
Congratulations Mark
Dr Lee's Professor of Anatomy, Emeritus, scientific advisor
1moGreat company. Best of luck